ESR1 and breast carcinoma: What is of note is that we observed that breast cancer cells with acquired resistance upregulate interferon signaling pathways and/or TNFα inflammatory signaling, as well as growth factor regulated pathways while downregulating estrogen receptor (ERα), which enable them to overcome the growth inhibition initially brought about by these compounds.